Medicamen BiotechMEDICAMEQ 
$4.80-2.90%24h
-2.90%24h
Global rank24020
Market cap$59.84M
Change 7d-1.76%
YTD Performance-33.88%
SP500 benchmarkUnderperform
P/E0.41
P/S3.56
Revenue$16.80M
Earnings$1.76M
Dividend yield-
Main Sector
Healthcare
Category
Medicamen Biotech MEDICAMEQ Total Debt
MEDICAMEQ Total Debt in 2022: $103.68K
According to Medicamen Biotech latest financial reports the total debt is $103.68K, an decrease of -82.86% to 2022. At the end of 2022 company had $604.93K total debt. This figure represents the debts and financial obligations that Medicamen Biotech combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Medicamen Biotech MEDICAMEQ Total Debt History from 2023 to 2022
-
Value:-
MEDICAMEQ Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $103.68K | -82.86% |
| 2022 | $604.93K | -20.78% |
| 2021 | $763.63K | 171.55% |
| 2020 | $281.21K | 11163.29% |
| 2019 | $2.50K | - |
View the Top Total Debt Stocks 
